Lignans As Anticancer Agents: Recent Advances in the Discovery and Development of Lignans As Anticancer Agents - Manmeet Kaur - Books - LAP LAMBERT Academic Publishing - 9783659182242 - August 20, 2012
In case cover and title do not match, the title is correct

Lignans As Anticancer Agents: Recent Advances in the Discovery and Development of Lignans As Anticancer Agents


Get an email once the item is available
Do you have a profile? Log in
Get notified about new Manmeet Kaur releases
Add to your iMusic wish list

Not rated yet

Cancer, an abnormal and uncontrolled cell division, has engulfed the lives of unlimited people till date. Etoposide and Teniposide are podophyllotoxin derivatives and have been used clinically for treatment of refractory testicular tumor and cancer. These compounds arrests cell growth by DNA topo II inhibition, which causes double strand breaks in DNA and known as non-interclating topo II inhibitors. They have many side effects, such as myelosuppression, poor water solubility, and the development of resistance so modification is done on it at various sites. Podophyllotoxin contains a five-ring system. Modification of the A-ring gave compounds having significant activity but less than that of Etoposide, whereas modification of the B-ring resulted in the loss of activity. E-ring is essential for its anticancer activity and D-ring in lactone form is preferred for better activity. The introduction of double bond in C-ring lowers the activity but modifications at the C-4 in C-ring with bulkier groups enhance anticancer activity. NK-611, GL-331 and Etoposide phosphate are water soluble derivatives of Etoposide with potent anticancer activity and are currently in clinical trials.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released August 20, 2012
ISBN13 9783659182242
Publishers LAP LAMBERT Academic Publishing
Pages 184
Dimensions 150 × 11 × 226 mm   ·   276 g
Language English  

More by Manmeet Kaur

Show all